ProQR Therapeutics (PRQR) Priced

Preclinical Dutch biotech developing an mRNA repair therapy for cystic fibrosis.

Health Care - Biotechnology

IPO Performance
Latest Trade $4.15 0.00 (0.0%)
First Day Return 13.3%
Return from IPO -68.1%
 
ProQR Therapeutics IPO News more
  • .
IPO Data
IPO File Date 08/14/2014
Offer Price $13.00
Price Range $11.00 - $13.00
Offer Shares (mm) 7.5
Deal Size ($mm) 98
 
IPO Data
IPO Date 09/17/2014
Offer Price $13.00
Price Range $11.00 - $13.00
Offer Shares (mm) 7.5
Deal Size ($mm) $98
 
Underwriters
more
Business Overview
Preclinical Dutch biotech developing an mRNA repair therapy for cystic fibrosis.
Preclinical Dutch biotech developing an mRNA repair therapy for cystic fibrosis.
more
Company Data
Headquarters Leiden, , Netherlands
Founded 2012
Employees 45
Website www.proqr-tx.com
 

Performance vs. IPO Index (IPOUSA)